These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1349419)

  • 1. International Symposium on Diabetes, Vascular Risks, and Gliclazide (Diamicron). Washington, DC, June 28, 1991.
    Metabolism; 1992 May; 41(5 Suppl 1):1-45. PubMed ID: 1349419
    [No Abstract]   [Full Text] [Related]  

  • 2. [Macroangiopathy and type 2 diabetes mellitus: significance of Diamicron].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1990; ():325-34. PubMed ID: 2195215
    [No Abstract]   [Full Text] [Related]  

  • 3. Gliclazide (diamicron) in metabolic and vascular treatment of diabetes mellitus.
    Forette B
    East Afr Med J; 1977 Oct; 54(10):579-81. PubMed ID: 608430
    [No Abstract]   [Full Text] [Related]  

  • 4. Diabetes and vascular disease: a new international trial.
    Patel A; Chalmers J; Chaturvedi V; Currie R; Monaghan H; Neal B
    Asian Cardiovasc Thorac Ann; 2003 Jun; 11(2):180-4. PubMed ID: 12878575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-insulin dependent diabetes. Role of gliclazide (diamicron)].
    Lesobre B
    Journ Annu Diabetol Hotel Dieu; 1995; ():313-22. PubMed ID: 7602890
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hypoglycemic effect of diamicron in diabetic patients].
    Balabolkin MI; Morozova TP; Zhizhina SA; Gavriliuk LI
    Klin Med (Mosk); 1983 Jan; 61(1):87-9. PubMed ID: 6834765
    [No Abstract]   [Full Text] [Related]  

  • 7. Gliclazide therapy of NIDDM in the 90s. Proceedings of 1st International Diamicron Symposium, September 24, 1990, Montreal, Canada.
    Diabetes Res Clin Pract; 1991; 14 Suppl 2():S1-92. PubMed ID: 1686583
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diamicron and micristin in the complex treatment of diabetes mellitus].
    Balabolkin MI; Golubiatnikova GA; Koroleva TV; Titova GP
    Ter Arkh; 1982; 54(10):32-6. PubMed ID: 7179117
    [No Abstract]   [Full Text] [Related]  

  • 9. [The real problem in diabetes (trial of gliclazide, an original molecule with metabolic and vascular properties)].
    Masbernard A; Portal A
    Therapeutique; 1972 Nov; 48(9):569-73. PubMed ID: 4650526
    [No Abstract]   [Full Text] [Related]  

  • 10. [The effect of diamicron on various blood coagulation indices in patients with type II diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Novikova NV; Nepsha VD
    Klin Med (Mosk); 1983 Apr; 61(4):66-8. PubMed ID: 6865293
    [No Abstract]   [Full Text] [Related]  

  • 11. Increased fibrinolytic potential induced by gliclazide in type I and type II diabetic patients.
    Gram J; Jespersen J
    Metabolism; 1992 May; 41(5 Suppl 1):25-9. PubMed ID: 1574011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with diamicron treatment of diabetics].
    Velikov VK; Shubina IO; Saltykov BB; Frolova AI
    Klin Med (Mosk); 1984 Nov; 62(11):99-101. PubMed ID: 6441072
    [No Abstract]   [Full Text] [Related]  

  • 13. [Comparative evaluation of the hypoglycemic effect of the 2d-generation sulfonylurea preparations maninil and diamicron in diabetes mellitus].
    Balabolkin MI; Morozova TP; Zhizhina SA; Levitskaia ZI; Gincherman LE
    Probl Endokrinol (Mosk); 1982; 28(5):9-11. PubMed ID: 6815639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Survey of 832 case records of diabetes of adult onset treated by Diamicron. Evolution of metabolism and weight].
    Estivals JP; Giraudet MC; Videau JY
    Journ Annu Diabetol Hotel Dieu; 1978; ():333-40. PubMed ID: 349228
    [No Abstract]   [Full Text] [Related]  

  • 15. [Significance of an oral antidiabetic with vascular action: gliclazide in the asymptomatic diabetes and patent diabetes].
    Journ Annu Diabetol Hotel Dieu; 1976 May; ():331-9. PubMed ID: 1011422
    [No Abstract]   [Full Text] [Related]  

  • 16. Gliclazide in the treatment of obese NIDDM patients.
    Kumar S; Keswani P; Bose BS; Agrawal JK
    J Assoc Physicians India; 1994 Feb; 42(2):176-7. PubMed ID: 7646644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gliclazide, a new molecule in the treatment of non-insulin-dependent diabetes mellitus].
    Bour H
    Rev Prat; 1980 Feb; 30(9):593-4. PubMed ID: 7361055
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapeutic value of a new hypoglycemic agent (gliclazide) in the treatment of diabetes mellitus].
    Polosa P; Mughini L
    Clin Ter; 1978 Jan; 84(2):135-40. PubMed ID: 648096
    [No Abstract]   [Full Text] [Related]  

  • 19. ABC of diabetes: treatment.
    Wheeley MS
    Br Med J (Clin Res Ed); 1982 Oct; 285(6350):1278. PubMed ID: 6812843
    [No Abstract]   [Full Text] [Related]  

  • 20. Gliclazide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in diabetes mellitus.
    Holmes B; Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1984 Apr; 27(4):301-27. PubMed ID: 6373223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.